Upgrade to SI Premium - Free Trial

Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald

October 16, 2026 7:33 AM
Cantor Fitzgerald analyst Carter Gould reiterated a Neutral rating and $28.00 price target on Pfizer (NYSE: PFE).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments